Filing Details
- Accession Number:
- 0001062993-18-003711
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-11 21:23:38
- Reporting Period:
- 2018-09-10
- Accepted Time:
- 2018-09-11 21:23:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1405235 | N Mark Wegman | C/O Biospecifics Technologies Corp. 35 Wilbur Street Lynbrook NY 11563 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Disposition | 2018-09-10 | 5,500 | $57.31 | 66,272 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2018-09-11 | 1,000 | $58.66 | 65,272 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The selling price of $57.3102 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $56.22 to $58.902. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The selling price of $58.655 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $58.64 to $58.67. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
